Welcome!
Tianjin Zhongxin Pharmaceutical
Results
Tianjin Zhongxin Pharma's 3Q2021 earnings rise 30% to $41.8mil on higher sales
In 9M2021, net attributable profit stood at RMB661.5 million, a 39% increase y-o-y.
October 29, 2021
Results
Tianjin Zhongxin posts 12% rise in 1Q earnings to $27 mil
SINGAPORE (April 28): Tianjin Zhongxin Pharmaceutical reported a 12% rise in 1Q earnings to RMB 133.7 million ($27 million) from a year ago.
April 28, 2017